Roller Mixer Influences Coagulation Tests
|
By LabMedica International staff writers Posted on 24 Nov 2011 |
|
Immediately after blood collection, the use of a roller mixer influences the ratio of rejected samples in coagulation tests.
Coagulation test results can be influenced easily by biological, preanalytical, and analytical factors due to the peculiar sensitivity of the assay methodology and the potentially adverse clinical consequences of spurious test results.
Clinical biochemists at the Ministry of Health Istanbul Research and Training Hospital (Istanbul, Turkey) retrospectively investigated blood samples collected in centralized units of outpatient clinics for prothrombin time (PT) with 24,050 in group I and 24,500 in group II. In group I, the tubes were inverted and left standing in horizontal position for less than 90 minutes at room temperature. In group II, the tubes were left standing on roller mixer for 3-5 minutes with 30 revolutions per minute (rpm).
On arrival at the clinical biochemistry laboratory, clotted samples were rejected according to “rejection criteria” defined in the laboratory procedure. Samples were rejected if before centrifugation, the clot was visible to the naked eye by moving the blood inside the tube. Samples that yield long clotting times were routinely checked for the reaction curve indicating a clot. The ratios of rejected samples of the two groups were compared statistically with chi-square analysis. The rate of rejection decreased significantly from 0.79% in group I to 0.20% in group II, the roller mixer group.
The authors concluded that using a roller mixer improves the reliability of coagulation testing. Such standardization in preanalytical phase may be helpful in preventing laboratory errors and obtaining correct test results in coagulation tests. They suggest that robotic mechanisms sending the tubes away from the roller exactly after one minute should probably be helpful in avoiding platelet activation. The study was published online on October 7, 2011, in the International Journal of Laboratory Hematology.
Related Links:
Ministry of Health Istanbul Research and Training Hospital
Coagulation test results can be influenced easily by biological, preanalytical, and analytical factors due to the peculiar sensitivity of the assay methodology and the potentially adverse clinical consequences of spurious test results.
Clinical biochemists at the Ministry of Health Istanbul Research and Training Hospital (Istanbul, Turkey) retrospectively investigated blood samples collected in centralized units of outpatient clinics for prothrombin time (PT) with 24,050 in group I and 24,500 in group II. In group I, the tubes were inverted and left standing in horizontal position for less than 90 minutes at room temperature. In group II, the tubes were left standing on roller mixer for 3-5 minutes with 30 revolutions per minute (rpm).
On arrival at the clinical biochemistry laboratory, clotted samples were rejected according to “rejection criteria” defined in the laboratory procedure. Samples were rejected if before centrifugation, the clot was visible to the naked eye by moving the blood inside the tube. Samples that yield long clotting times were routinely checked for the reaction curve indicating a clot. The ratios of rejected samples of the two groups were compared statistically with chi-square analysis. The rate of rejection decreased significantly from 0.79% in group I to 0.20% in group II, the roller mixer group.
The authors concluded that using a roller mixer improves the reliability of coagulation testing. Such standardization in preanalytical phase may be helpful in preventing laboratory errors and obtaining correct test results in coagulation tests. They suggest that robotic mechanisms sending the tubes away from the roller exactly after one minute should probably be helpful in avoiding platelet activation. The study was published online on October 7, 2011, in the International Journal of Laboratory Hematology.
Related Links:
Ministry of Health Istanbul Research and Training Hospital
Gold Member
Hybrid Pipette
SWITCH
Homocysteine Quality Control
Liquichek Homocysteine Control
Clinical Chemistry System
P780
Latest Technology News
- Robotic Technology Unveiled for Automated Diagnostic Blood Draws
- ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
- Aptamer Biosensor Technology to Transform Virus Detection
- AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
- AI-Generated Sensors Open New Paths for Early Cancer Detection
- Pioneering Blood Test Detects Lung Cancer Using Infrared Imaging
- AI Predicts Colorectal Cancer Survival Using Clinical and Molecular Features
- Diagnostic Chip Monitors Chemotherapy Effectiveness for Brain Cancer
- Machine Learning Models Diagnose ALS Earlier Through Blood Biomarkers
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more